GLP-1 agonist exenatide inhibits migration and proliferation in tumor cells

张瑞; 刘羞菲; 王慧; 王小翠; 童强; 郑宏庭

您当前的位置：

首页 >

文章列表页 >

GLP-1 agonist exenatide inhibits migration and proliferation in tumor cells

更新时间：2026-01-09

- GLP-1 agonist exenatide inhibits migration and proliferation in tumor cells
- Journal of Army Medical University Vol. 36, Issue 17, Pages: 1785-1789(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-37;R730.23;R977.15
- Published：2014
- 稿件说明：
移动端阅览
张瑞,刘羞菲,王慧,王小翠,童强,郑宏庭.GLP-1受体激动剂艾塞那肽对肿瘤细胞增殖、迁移的影响[J].陆军军医大学学报(原第三军医大学学报),2014,36(17):1785-1789.

　Zhang Rui,Liu Xiufei,Wang Hui,Wang Xiaocui,Tong Qiang,Zheng Hongting.GLP-1 agonist exenatide inhibits migration and proliferation in tumor cells[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(17):1785-1789.
张瑞,刘羞菲,王慧,王小翠,童强,郑宏庭.GLP-1受体激动剂艾塞那肽对肿瘤细胞增殖、迁移的影响[J].陆军军医大学学报(原第三军医大学学报),2014,36(17):1785-1789. DOI：

　Zhang Rui,Liu Xiufei,Wang Hui,Wang Xiaocui,Tong Qiang,Zheng Hongting.GLP-1 agonist exenatide inhibits migration and proliferation in tumor cells[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(17):1785-1789. DOI：

摘要

目的目的通过体外细胞实验观察胰高血糖素样肽-1（glucagon-like peptide-1，GLP-1）受体激动剂艾塞那肽对乳腺癌、结肠癌、胰腺癌3种肿瘤细胞增殖、迁移的影响。方法选取乳腺癌MDA-MB-231细胞、结肠癌HCT116细胞、胰腺癌HS766T细胞作为研究对象，每种细胞分为对照组、二甲双胍组、艾塞那肽组。利用CCK-8分别检测3种肿瘤细胞艾塞那肽干预72 h后的增殖能力；利用Transwell小室法观察培养12 h后3种肿瘤细胞的迁移能力。结果艾塞那肽组与对照组相比， MDA-MB-231细胞、HCT116细胞的增殖受到明显抑制（P0.01，P0.05），而HS766T细胞增殖无影响（P0.05）。Transwell体外细胞迁移实验结果显示，艾塞那肽组与对照组相比， MDA-MB-231细胞、HCT116细胞迁移受到明显抑制（P0.01，P0.05），但HS766T细胞迁移却显著增加（P0.01）。结论 GLP-1受体激动剂艾塞那肽可以抑制乳腺癌、结肠癌细胞的增殖与迁移，不影响胰腺癌细胞增殖，却促进其迁移，其对不同肿瘤细胞的影响具有差异性。

Abstract

Objective To determine the effect of glucagon-like peptide-1 (GLP-1) agonist exenatide on the proliferation and migration in breast cancer

colon cancer

and pancreatic cancer cells in vitro. Methods Breast cancer cell line MDA-MB-231

colon cancer cell line HCT116 and pancreatic cell line HS766T were selected as experimental subjects. Each type of cells was divided into control group

metformin group and exenatide group. After administration of metformin and exenatide respectively

CCK-8 assay was used for the proliferation detection in each group in 72 h after treatment

and the migration of tumor cells was observed using Transwell chamber assay in 12 h after treatment. Results Compared with the control group

the proliferation of MDA-MB-231 cells in exenatide group was significantly inhibited (P0.01)

the proliferation of HCT116 cells were inhibited (P0.05)

and the proliferation of HS766T was not affected (P0.05). Transwell migration assay showed that MDA-MB-231 cell migration was significantly inhibited by exenatide (P0.01)

HCT116 cell migration was also inhibited (P0.05)

but cell migration in HS766T group was significantly increased by exenatide (P0.01). Conclusion Exenatide inhibits the proliferation and migration in breast cancer cells and colon cancer cells. It has no effect on the proliferation

but promotes the migration in pancreatic cancer cells. Exenatide exerts different effects on different tumor cells.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Inhibitory effects of microRNA-206 on migration and invasion of breast cancer by targeting Cx43

Effect of exenatide treatment on visceral fat and early renal injury in overweight/obese T2DM patients

Lactobacilli culture supernatant enhances sensitivity of triplenegative breast cancer cells to cisplatin via down-regulation of Piwil2

Group psychotherapy reduces illness stigma in patients after breast modified radical mastectomy

Effect of miR-335 on biological behavior of breast cancer MDA-MB-231 cells

Related Author

杜俊泽

范林军

齐晓伟

孙鹏

王明浩

明佳

姜军

乔巧

Related Institution

No data

⁰